查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1415358

CT/NG 檢測市場：按產品類型、技術和最終用戶分類 - 2024-2030 年全球預測

CT/NG Testing Market by Product (Assays & Kits, Instruments & Analyzers), Testing Type (Lab Tests, PoC Tests), Technology, End User - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年CT/NG檢測市場規模為16.3億美元，預計2024年將達17.4億美元，2030年將達到26.9億美元，複合年成長率為7.41%。

CT/NG 檢測的全球市場

主要市場統計
基準年[2023] 16.3億美元
預測年份 [2024] 17.4億美元
預測年份 [2030] 26.9億美元
複合年成長率（%） 7.41%
CT/NG檢查市場-IMG1

CT/NG 檢測的重點是準確診斷、管理和預防性性行為感染(STI)，包括披衣菌感染披衣菌 (CT) 和淋病奈瑟菌 (NG)。世界各地披衣菌感染和淋病感染的盛行率不斷上升，以及人們對未經治療的性傳染病相關風險的認知不斷提高，也迫切需要及時識別和採取適當的治療方案。診斷技術的進步提供了提高檢測準確性並最大限度縮短 CT/NG 感染週轉時間的機會。 POC檢測套組的開發受到了廣泛歡迎，因為它們無需實驗室基礎設施即可快速獲得結果，從而更快地做出臨床決策。然而，與先進診斷測試相關的高成本以及各國政府關於診斷測試的法規差異限制了全球產品的普及。然而，政府主導的舉措分子診斷的採用和推廣性傳播感染篩檢計劃以促進早期發現和預防與未經治療的感染疾病相關的併發症的舉措正在推動 CT/NG 檢測市場的發展。

區域洞察

對性行為感染感染 (STI) 即時診斷的需求不斷成長，披衣菌感染和淋病感染疾病不斷上升，以及政府針對早期檢測和治療的舉措，將增加對 CT/NG 檢測的需求。在歐盟國家，人們對應對公共衛生挑戰的性傳染感染預防計畫越來越感興趣，透過監測改善診斷方法的投資正在為 CT/NG 檢測市場做出貢獻。由於政府加強提高性傳染感染意識和改善醫療保健服務的可近性，中東和非洲地區的 CT/NG 檢測具有巨大的成長潛力。該地區人口眾多，亞太地區政府的教育宣傳活動提高了人們對性健康的認知，因此對於 CT/NG 檢測市場來說是一個利潤豐厚的市場。

FPNV定位矩陣

FPNV定位矩陣對於評估CT/NG檢查市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對 CT/NG 檢測市場中供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-CT/NG檢測市場的市場規模和預測是多少？

2-CT/NG 檢測市場預測期間需要考慮投資的產品、細分市場、應用和領域有哪些？

3-CT/NG檢測市場的技術趨勢和法律規範是什麼？

4-CT/NG檢測市場主要廠商的市場佔有率是多少？

5-進入CT/NG檢測市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 全球性行為感染傳染感染的盛行率不斷上升
      • 提高對未經治療的感染疾病的影響的認知
      • 對即時 (POC) 測試設備的需求不斷成長
    • 抑制因素
      • 與先進診斷設備相關的高成本
    • 機會
      • 政府推動性健康教育的舉措
      • 整合自動化系統以提高工作流程效率
    • 任務
      • 透過 CT/NG 檢測發現抗生素抗藥性菌株
  • 市場區隔分析
    • 產品：快速部署儀器和分析儀以提供一致的結果
    • 測試類型：CT/NG PoC測試越來越流行
    • 技術：基於聚合酶鍊式反應 (PCR) 的 CT/NG 測試的進步，將準確性置於成本和速度之上
    • 最終使用者：醫院和診所現場護理檢測的普及
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章 CT/NG 檢查市場：依產品分類

  • 檢測方法和套件
  • 測量儀器和分析設備

第7章 CT/NG 檢查市場（依測試類型）

  • 臨床檢查
  • 概念驗證測試

第8章 CT/NG 檢查市場：依技術分類

  • 免疫診斷
  • 恒溫核酸增幅技術
  • 聚合酶鍊式反應

第 9 章 CT/NG 檢查市場：依最終使用者分類

  • 臨床實驗室
  • 醫院和診所

第10章 北美、南美CT/NG檢測市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區CT/NG檢測市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東、非洲CT/NG檢測市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 合約、合作和夥伴關係
    • 新產品發布和功能增強
    • 獎項/獎勵/擴展

第14章競爭產品組合

  • 主要公司簡介
    • Abbott Laboratories
    • Becton, Dickinson and Company
    • Binx Health, Inc.
    • Bio-Rad Laboratories, Inc.
    • Bioneer Corporation
    • Danaher Corporation
    • ELITech Group SAS
    • F. Hoffmann-La Roche Ltd.
    • Geneproof AS
    • Genetic Signatures Ltd.
    • Goffin Molecular Technologies BV
    • Hologic, Inc.
    • Meridian Bioscience Inc.
    • Microbiologics, Inc.
    • Molbio Diagnostics Pvt. Ltd.
    • Operon SA
    • PerkinElmer Inc.
    • QIAGEN NV
    • Sansure Biotech Inc.
    • Seegene, Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Tianlong Technology Co., Ltd.
    • Vircell SL
    • Visby Medical, Inc.
  • 主要產品系列

第15章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-777F3B3232C0

[188 Pages Report] The CT/NG Testing Market size was estimated at USD 1.63 billion in 2023 and expected to reach USD 1.74 billion in 2024, at a CAGR 7.41% to reach USD 2.69 billion by 2030.

Global CT/NG Testing Market

KEY MARKET STATISTICS
Base Year [2023] USD 1.63 billion
Estimated Year [2024] USD 1.74 billion
Forecast Year [2030] USD 2.69 billion
CAGR (%) 7.41%
CT/NG Testing Market - IMG1

The CT/NG testing is primarily focused on the accurate diagnosis, management, and prevention of sexually transmitted infections (STIs), including Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG). The increasing prevalence of chlamydia and gonorrhea infections worldwide and rising awareness about the risks associated with untreated STIs also fuel the need for timely identification and appropriate treatment options. Technological diagnostics advancements offer opportunities for improving accuracy in detecting CT/NG infections while minimizing turnaround times. The development of POC test kits, allowing rapid results without any need for laboratory infrastructure, has gained immense popularity since it enables faster clinical decision-making. However, high costs associated with advanced diagnostic tests coupled with variations in government regulations across different countries concerning diagnostic tests limit product penetration worldwide. Nevertheless, the growing adoption of molecular diagnostics methods and government-led initiatives to promote STI screening programs to facilitate early detection and prevention of complications associated with untreated infections contribute positively to the growth of the CT/NG testing market.

Regional Insights

A growing demand for point-of-care diagnostics for sexually transmitted infections (STIs), increasing prevalence of chlamydia and gonorrhea infections, and government initiatives targeting early detection and treatment have expanded the need for CT/NG testing. In the EU countries, a rising focus on STI prevention programs to address the public health challenges investments for improving diagnostic methods through research contribute to the CT/NG testing market. The Middle East & Africa region exhibits significant potential for CT/NG testing growth due to increased government efforts towards improving STI awareness and access to healthcare services. With a large population and growing awareness around sexual health following education campaigns by the Asia-Pacific government, the region presents a lucrative CT/NG testing market.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the CT/NG Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the CT/NG Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the CT/NG Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Becton, Dickinson and Company, Binx Health, Inc., Bio-Rad Laboratories, Inc., Bioneer Corporation, Danaher Corporation, ELITech Group SAS, F. Hoffmann-La Roche Ltd., Geneproof A.S., Genetic Signatures Ltd., Goffin Molecular Technologies B.V., Hologic, Inc., Meridian Bioscience Inc., Microbiologics, Inc., Molbio Diagnostics Pvt. Ltd., Operon S.A., PerkinElmer Inc., QIAGEN N.V., Sansure Biotech Inc., Seegene, Inc., Siemens Healthineers AG, Thermo Fisher Scientific Inc., Tianlong Technology Co., Ltd., Vircell S.L., and Visby Medical, Inc..

Market Segmentation & Coverage

This research report categorizes the CT/NG Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Assays & Kits
    • Instruments & Analyzers
  • Testing Type
    • Lab Tests
    • PoC Tests
  • Technology
    • Immunodiagnostics
    • Isothermal Nucleic Acid Amplification Technology
    • Polymerase Chain Reaction
  • End User
    • Clinical Laboratories
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the CT/NG Testing Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the CT/NG Testing Market?

3. What are the technology trends and regulatory frameworks in the CT/NG Testing Market?

4. What is the market share of the leading vendors in the CT/NG Testing Market?

5. Which modes and strategic moves are suitable for entering the CT/NG Testing Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. CT/NG Testing Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of STIs worldwide
      • 5.1.1.2. Growing awareness about the consequences of untreated infections
      • 5.1.1.3. Rising need for point-of-care (POC) testing devices
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with advanced diagnostic equipment
    • 5.1.3. Opportunities
      • 5.1.3.1. Government initiatives for promoting sexual health education
      • 5.1.3.2. Integration of automation systems to enhance workflow efficiency
    • 5.1.4. Challenges
      • 5.1.4.1. Emergence of antibiotic-resistant strains by CT/NG testing
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Rapid adoption of instruments and analyzers for providing consistent results
    • 5.2.2. Testing Type: Gaining popularity of PoC tests for CT/NG
    • 5.2.3. Technology: Advancing Polymerase Chain Reaction (PCR)-based CT/NG testing for prioritizing accuracy over cost and speed
    • 5.2.4. End User: Popularity of point-of-care testing for hospital and clinic settings
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. CT/NG Testing Market, by Product

  • 6.1. Introduction
  • 6.2. Assays & Kits
  • 6.3. Instruments & Analyzers

7. CT/NG Testing Market, by Testing Type

  • 7.1. Introduction
  • 7.2. Lab Tests
  • 7.3. PoC Tests

8. CT/NG Testing Market, by Technology

  • 8.1. Introduction
  • 8.2. Immunodiagnostics
  • 8.3. Isothermal Nucleic Acid Amplification Technology
  • 8.4. Polymerase Chain Reaction

9. CT/NG Testing Market, by End User

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Hospitals & Clinics

10. Americas CT/NG Testing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific CT/NG Testing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa CT/NG Testing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. Agreement, Collaboration, & Partnership
      • 13.3.1.1. binx health Announces Strategic Supply Agreement with Afaxys to Expand Sexual Health Test Access to Thousands of Clinics Nationally
    • 13.3.2. New Product Launch & Enhancement
      • 13.3.2.1. Bio-Rad Launches Exact Diagnostics CT/NG, STI Run Controls
    • 13.3.3. Award, Recognition, & Expansion
      • 13.3.3.1. Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Abbott Laboratories
    • 14.1.2. Becton, Dickinson and Company
    • 14.1.3. Binx Health, Inc.
    • 14.1.4. Bio-Rad Laboratories, Inc.
    • 14.1.5. Bioneer Corporation
    • 14.1.6. Danaher Corporation
    • 14.1.7. ELITech Group SAS
    • 14.1.8. F. Hoffmann-La Roche Ltd.
    • 14.1.9. Geneproof A.S.
    • 14.1.10. Genetic Signatures Ltd.
    • 14.1.11. Goffin Molecular Technologies B.V.
    • 14.1.12. Hologic, Inc.
    • 14.1.13. Meridian Bioscience Inc.
    • 14.1.14. Microbiologics, Inc.
    • 14.1.15. Molbio Diagnostics Pvt. Ltd.
    • 14.1.16. Operon S.A.
    • 14.1.17. PerkinElmer Inc.
    • 14.1.18. QIAGEN N.V.
    • 14.1.19. Sansure Biotech Inc.
    • 14.1.20. Seegene, Inc.
    • 14.1.21. Siemens Healthineers AG
    • 14.1.22. Thermo Fisher Scientific Inc.
    • 14.1.23. Tianlong Technology Co., Ltd.
    • 14.1.24. Vircell S.L.
    • 14.1.25. Visby Medical, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. CT/NG TESTING MARKET RESEARCH PROCESS
  • FIGURE 2. CT/NG TESTING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CT/NG TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. CT/NG TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. CT/NG TESTING MARKET DYNAMICS
  • FIGURE 7. CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. CT/NG TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2030 (%)
  • FIGURE 10. CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 12. CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. CT/NG TESTING MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. CT/NG TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. CT/NG TESTING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CT/NG TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CT/NG TESTING MARKET SIZE, BY ASSAYS & KITS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CT/NG TESTING MARKET SIZE, BY INSTRUMENTS & ANALYZERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. CT/NG TESTING MARKET SIZE, BY LAB TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CT/NG TESTING MARKET SIZE, BY POC TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. CT/NG TESTING MARKET SIZE, BY IMMUNODIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CT/NG TESTING MARKET SIZE, BY ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. CT/NG TESTING MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 16. CT/NG TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. CT/NG TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CT/NG TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CT/NG TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TESTING TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM CT/NG TESTING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. CT/NG TESTING MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 187. CT/NG TESTING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 188. CT/NG TESTING MARKET LICENSE & PRICING